Detalhe da pesquisa
1.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972026
2.
Indocyanine green angiography guidance for vascular preservation in skin and nipple sparing mastectomy.
Breast Cancer Res Treat
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662118
3.
Financial toxicity in BRCA1 and BRCA2 carriers.
Gynecol Oncol
; 170: 160-166, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701836
4.
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Gynecol Oncol
; 177: 20-31, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625235
5.
The impact of converting to telehealth for cancer genetic counseling and testing during the COVID-19 pandemic.
J Genet Couns
; 2023 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740447
6.
Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not.
Ann Surg Oncol
; 29(10): 6225-6233, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35951135
7.
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Am J Obstet Gynecol
; 227(1): 61.e1-61.e18, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216968
8.
Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy.
Support Care Cancer
; 31(1): 32, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517706
9.
Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
J Genet Couns
; 30(6): 1570-1581, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904624
10.
Sexual Dysfunction in Survivorship; the Impact of Menopause and Endocrine Therapy.
Ann Surg Oncol
; 26(10): 3159-3165, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342358
11.
Gender and the Balance of Parenting and Professional Life among Gynecology Subspecialists.
J Minim Invasive Gynecol
; 26(6): 1088-1094, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30389582
12.
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 151(2): 257-263, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30177462
13.
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer.
Gynecol Oncol
; 150(2): 274-281, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804638
14.
ASO Visual Abstract: Breast-Specific Sensuality in Breast Cancer Survivors - Sexually Active or Not.
Ann Surg Oncol
; 29(10): 6236-6237, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904653
15.
Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?
Ann Surg Oncol
; 24(11): 3133-3140, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608119
16.
Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Gynecol Oncol
; 146(1): 137-145, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483269
17.
Advance care planning as a shared endeavor: completion of ACP documents in a multidisciplinary cancer program.
Psychooncology
; 26(1): 67-73, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26489363
18.
Predicting Breast Tumor Size for Pre-operative Planning: Which Imaging Modality is Best?
Breast J
; 23(1): 52-58, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612172
19.
Obesity risk awareness in women with endometrial cancer.
Arch Gynecol Obstet
; 295(4): 965-969, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168655
20.
Influential Forces in Breast Cancer Surgical Decision Making and the Impact on Body Image and Sexual Function.
Ann Surg Oncol
; 23(10): 3403-11, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27364508